18 May 2026
18 May 2026
TRAQ aims to stabilise the SI joint by bi-cortical fixation and its triangular piercing barbs engage both cortices.
The double-blind, randomised trial tested two dosing regimens against a pembrolizumab monotherapy.
The approval covers the use of Enhertu in both the neoadjuvant and adjuvant treatment settings for adult patients.
The rollout will allow Ardent’s care teams to view patient imaging information in one system.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
